This issue of Rheumatic Disease Clinics, guest edited by Drs. Laura Schanberg and Yukiko Kimura, will focus on Pediatric Rheumatology. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Part II, also edited by Drs. Kimura and Schanberg, will publish subsequently and cover additional topics relevant for pediatric rheumatologists. Topics discussed in this issue include but are not limited to: TMJ, CNO (CRMO), Update JIA treatment, Pharmacology of biologics in kids, Juvenile Spondylitis, Juvenile fibro update, JDM update, Pediatric Sjogrens, Localized scleroderma, Systemic Sclerosis, Uveitis, COVID-19 in pediatrics, Recent advances in pediatric vasculitis, and Autoinflammatory diseases.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xiv 7. Foreword - p. xv 8. Preface - p. xvii 9. CARRA: The Childhood Arthritis and Rheumatology Research Alliance - p. 531 10. Juvenile Idiopathic Arthritis Treatment Updates - p. 545 11. Recent Updates in Juvenile Spondyloarthritis - p. 565 12. Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis: Refractory Arthritis, Recurrent Macrophage Activation Syndrome and Chronic Lung Disease - p. 585 13. The Temporomandibular Joint in Juvenile Idiopathic Arthritis - p. 607 14. Uveitis in Children and Adolescents - p. 619 15. Pharmacosurveillance in Juvenile Idiopathic Arthritis - p. 643 16. Outcome Measures in Pediatric Rheumatic Disease - p. 655 17. Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes - p. 669 18. Chronic Nonbacterial Osteomyelitis: Insights into Pathogenesis, Assessment, and Treatment - p. 691 19. Unique Aspects of Pediatric Sjögren Disease - p. 707 20. Juvenile Fibromyalgia - p. 725 21. Juvenile Localized Scleroderma: Updates and Differences from Adult-Onset Disease - p. 737 22. Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma - p. 757 23. Recent Advances in Pediatric Vasculitis - p. 781 24. COVID-19 in Pediatrics - p. 797
This issue of Rheumatic Disease Clinics, guest edited by Drs. Laura Schanberg and Yukiko Kimura, will focus on Pediatric Rheumatology. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Part II, also edited by Drs. Kimura and Schanberg, will publish subsequently and cover additional topics relevant for pediatric rheumatologists. Topics discussed in this issue include but are not limited to: TMJ, CNO (CRMO), Update JIA treatment, Pharmacology of biologics in kids, Juvenile Spondylitis, Juvenile fibro update, JDM update, Pediatric Sjogrens, Localized scleroderma, Systemic Sclerosis, Uveitis, COVID-19 in pediatrics, Recent advances in pediatric vasculitis, and Autoinflammatory diseases.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xiv 7. Foreword - p. xv 8. Preface - p. xvii 9. CARRA: The Childhood Arthritis and Rheumatology Research Alliance - p. 531 10. Juvenile Idiopathic Arthritis Treatment Updates - p. 545 11. Recent Updates in Juvenile Spondyloarthritis - p. 565 12. Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis: Refractory Arthritis, Recurrent Macrophage Activation Syndrome and Chronic Lung Disease - p. 585 13. The Temporomandibular Joint in Juvenile Idiopathic Arthritis - p. 607 14. Uveitis in Children and Adolescents - p. 619 15. Pharmacosurveillance in Juvenile Idiopathic Arthritis - p. 643 16. Outcome Measures in Pediatric Rheumatic Disease - p. 655 17. Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes - p. 669 18. Chronic Nonbacterial Osteomyelitis: Insights into Pathogenesis, Assessment, and Treatment - p. 691 19. Unique Aspects of Pediatric Sjögren Disease - p. 707 20. Juvenile Fibromyalgia - p. 725 21. Juvenile Localized Scleroderma: Updates and Differences from Adult-Onset Disease - p. 737 22. Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma - p. 757 23. Recent Advances in Pediatric Vasculitis - p. 781 24. COVID-19 in Pediatrics - p. 797
